Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Watchlist Manager
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Watchlist
Price: 437.01 USD -1.14% Market Closed
Market Cap: 110.9B USD

Wall Street
Price Targets

VRTX Price Targets Summary
Vertex Pharmaceuticals Inc

Wall Street analysts forecast VRTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VRTX is 496.99 USD with a low forecast of 333.3 USD and a high forecast of 634.2 USD.

Lowest
Price Target
333.3 USD
24% Downside
Average
Price Target
496.99 USD
14% Upside
Highest
Price Target
634.2 USD
45% Upside
Vertex Pharmaceuticals Inc Competitors:
Price Targets
CLYM
Climb Bio Inc
394% Upside
ELIC
Elicera Therapeutics AB
43% Upside
SLNO
Soleno Therapeutics Inc
132% Upside
MIRM
Mirum Pharmaceuticals Inc
37% Upside
DVAX
Dynavax Technologies Corp
94% Upside
688177
Bio-Thera Solutions Ltd
57% Upside
688105
Nanjing Vazyme Biotech Co Ltd
33% Upside
EXAS
Exact Sciences Corp
1% Downside

Revenue
Forecast

Revenue Estimate
Vertex Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Vertex Pharmaceuticals Inc's revenue is 17%. The projected CAGR for the next 3 years is 10%.

17%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vertex Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Vertex Pharmaceuticals Inc's operating income is 26%. The projected CAGR for the next 3 years is 16%.

26%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Net Income
Forecast

Net Income Estimate
Vertex Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VRTX's stock price target?
Price Target
496.99 USD

According to Wall Street analysts, the average 1-year price target for VRTX is 496.99 USD with a low forecast of 333.3 USD and a high forecast of 634.2 USD.

What is Vertex Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Vertex Pharmaceuticals Inc's revenue is 17%. The projected CAGR for the next 3 years is 10%.

What is Vertex Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Vertex Pharmaceuticals Inc's operating income is 26%. The projected CAGR for the next 3 years is 16%.

Back to Top